Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 12 |
GO:0031515 | tRNA (m1A) methyltransferase complex | 6 | 12 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0034708 | methyltransferase complex | 4 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0043229 | intracellular organelle | 3 | 12 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 12 |
GO:0043527 | tRNA methyltransferase complex | 5 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:1902494 | catalytic complex | 2 | 12 |
GO:1990234 | transferase complex | 3 | 12 |
GO:0005643 | nuclear pore | 3 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: E9AU12
Term | Name | Level | Count |
---|---|---|---|
GO:0001510 | RNA methylation | 4 | 12 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006399 | tRNA metabolic process | 7 | 12 |
GO:0006400 | tRNA modification | 6 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008033 | tRNA processing | 8 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009451 | RNA modification | 5 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0030488 | tRNA methylation | 5 | 12 |
GO:0032259 | methylation | 2 | 12 |
GO:0034470 | ncRNA processing | 7 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034660 | ncRNA metabolic process | 6 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0043414 | macromolecule methylation | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0008168 | methyltransferase activity | 4 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 442 | 446 | PF00656 | 0.630 |
CLV_C14_Caspase3-7 | 76 | 80 | PF00656 | 0.335 |
CLV_C14_Caspase3-7 | 82 | 86 | PF00656 | 0.278 |
CLV_NRD_NRD_1 | 107 | 109 | PF00675 | 0.391 |
CLV_NRD_NRD_1 | 139 | 141 | PF00675 | 0.164 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.416 |
CLV_PCSK_KEX2_1 | 107 | 109 | PF00082 | 0.391 |
CLV_PCSK_KEX2_1 | 139 | 141 | PF00082 | 0.169 |
CLV_PCSK_KEX2_1 | 389 | 391 | PF00082 | 0.540 |
CLV_PCSK_KEX2_1 | 437 | 439 | PF00082 | 0.645 |
CLV_PCSK_PC1ET2_1 | 139 | 141 | PF00082 | 0.179 |
CLV_PCSK_PC1ET2_1 | 389 | 391 | PF00082 | 0.540 |
CLV_PCSK_PC1ET2_1 | 437 | 439 | PF00082 | 0.645 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 201 | 205 | PF00082 | 0.452 |
CLV_PCSK_SKI1_1 | 243 | 247 | PF00082 | 0.519 |
CLV_PCSK_SKI1_1 | 28 | 32 | PF00082 | 0.363 |
CLV_PCSK_SKI1_1 | 314 | 318 | PF00082 | 0.397 |
CLV_PCSK_SKI1_1 | 438 | 442 | PF00082 | 0.727 |
DOC_CDC14_PxL_1 | 422 | 430 | PF14671 | 0.430 |
DOC_CKS1_1 | 414 | 419 | PF01111 | 0.627 |
DOC_MAPK_gen_1 | 181 | 189 | PF00069 | 0.305 |
DOC_MAPK_gen_1 | 27 | 34 | PF00069 | 0.391 |
DOC_MAPK_MEF2A_6 | 183 | 191 | PF00069 | 0.305 |
DOC_MAPK_MEF2A_6 | 27 | 34 | PF00069 | 0.426 |
DOC_MAPK_MEF2A_6 | 368 | 376 | PF00069 | 0.393 |
DOC_MAPK_MEF2A_6 | 389 | 397 | PF00069 | 0.454 |
DOC_PP2B_LxvP_1 | 162 | 165 | PF13499 | 0.452 |
DOC_PP2B_LxvP_1 | 245 | 248 | PF13499 | 0.545 |
DOC_PP2B_LxvP_1 | 423 | 426 | PF13499 | 0.428 |
DOC_USP7_MATH_1 | 321 | 325 | PF00917 | 0.347 |
DOC_USP7_UBL2_3 | 139 | 143 | PF12436 | 0.307 |
DOC_USP7_UBL2_3 | 251 | 255 | PF12436 | 0.461 |
DOC_WW_Pin1_4 | 317 | 322 | PF00397 | 0.510 |
DOC_WW_Pin1_4 | 351 | 356 | PF00397 | 0.398 |
DOC_WW_Pin1_4 | 413 | 418 | PF00397 | 0.617 |
LIG_14-3-3_CanoR_1 | 153 | 159 | PF00244 | 0.426 |
LIG_14-3-3_CanoR_1 | 181 | 190 | PF00244 | 0.275 |
LIG_14-3-3_CanoR_1 | 219 | 227 | PF00244 | 0.375 |
LIG_14-3-3_CanoR_1 | 253 | 258 | PF00244 | 0.212 |
LIG_14-3-3_CanoR_1 | 438 | 447 | PF00244 | 0.569 |
LIG_14-3-3_CanoR_1 | 60 | 64 | PF00244 | 0.284 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.588 |
LIG_Clathr_ClatBox_1 | 148 | 152 | PF01394 | 0.426 |
LIG_CtBP_PxDLS_1 | 357 | 361 | PF00389 | 0.423 |
LIG_FAT_LD_1 | 112 | 120 | PF03623 | 0.426 |
LIG_FHA_1 | 182 | 188 | PF00498 | 0.328 |
LIG_FHA_1 | 206 | 212 | PF00498 | 0.391 |
LIG_FHA_1 | 237 | 243 | PF00498 | 0.426 |
LIG_FHA_1 | 29 | 35 | PF00498 | 0.378 |
LIG_FHA_1 | 303 | 309 | PF00498 | 0.535 |
LIG_FHA_1 | 41 | 47 | PF00498 | 0.343 |
LIG_FHA_1 | 439 | 445 | PF00498 | 0.569 |
LIG_FHA_2 | 116 | 122 | PF00498 | 0.335 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.335 |
LIG_IRF3_LxIS_1 | 372 | 377 | PF10401 | 0.452 |
LIG_LIR_Gen_1 | 361 | 372 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 252 | 257 | PF02991 | 0.376 |
LIG_LIR_Nem_3 | 339 | 344 | PF02991 | 0.281 |
LIG_LIR_Nem_3 | 361 | 367 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 66 | 72 | PF02991 | 0.301 |
LIG_LIR_Nem_3 | 9 | 15 | PF02991 | 0.365 |
LIG_LYPXL_yS_3 | 69 | 72 | PF13949 | 0.321 |
LIG_NRBOX | 111 | 117 | PF00104 | 0.426 |
LIG_PCNA_PIPBox_1 | 334 | 343 | PF02747 | 0.220 |
LIG_SH2_CRK | 145 | 149 | PF00017 | 0.324 |
LIG_SH2_CRK | 50 | 54 | PF00017 | 0.424 |
LIG_SH2_PTP2 | 12 | 15 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 12 | 15 | PF00017 | 0.342 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.251 |
LIG_SH2_STAT5 | 403 | 406 | PF00017 | 0.344 |
LIG_SH3_1 | 255 | 261 | PF00018 | 0.424 |
LIG_SH3_3 | 255 | 261 | PF00018 | 0.504 |
LIG_SH3_3 | 349 | 355 | PF00018 | 0.378 |
LIG_SH3_3 | 411 | 417 | PF00018 | 0.601 |
LIG_SUMO_SIM_anti_2 | 184 | 191 | PF11976 | 0.305 |
LIG_TRAF2_1 | 440 | 443 | PF00917 | 0.700 |
LIG_TRAF2_1 | 458 | 461 | PF00917 | 0.495 |
LIG_UBA3_1 | 115 | 122 | PF00899 | 0.391 |
LIG_UBA3_1 | 226 | 232 | PF00899 | 0.309 |
LIG_UBA3_1 | 404 | 409 | PF00899 | 0.379 |
MOD_CDK_SPK_2 | 413 | 418 | PF00069 | 0.347 |
MOD_CK1_1 | 125 | 131 | PF00069 | 0.395 |
MOD_CK1_1 | 215 | 221 | PF00069 | 0.452 |
MOD_CK2_1 | 115 | 121 | PF00069 | 0.305 |
MOD_CK2_1 | 436 | 442 | PF00069 | 0.701 |
MOD_CK2_1 | 455 | 461 | PF00069 | 0.612 |
MOD_CK2_1 | 59 | 65 | PF00069 | 0.335 |
MOD_CK2_1 | 96 | 102 | PF00069 | 0.305 |
MOD_GlcNHglycan | 121 | 125 | PF01048 | 0.373 |
MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.426 |
MOD_GlcNHglycan | 273 | 276 | PF01048 | 0.643 |
MOD_GlcNHglycan | 302 | 305 | PF01048 | 0.347 |
MOD_GlcNHglycan | 36 | 39 | PF01048 | 0.338 |
MOD_GlcNHglycan | 418 | 421 | PF01048 | 0.575 |
MOD_GlcNHglycan | 428 | 431 | PF01048 | 0.666 |
MOD_GlcNHglycan | 438 | 441 | PF01048 | 0.758 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.355 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.308 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.700 |
MOD_GSK3_1 | 317 | 324 | PF00069 | 0.468 |
MOD_GSK3_1 | 391 | 398 | PF00069 | 0.454 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.377 |
MOD_LATS_1 | 436 | 442 | PF00433 | 0.561 |
MOD_N-GLC_1 | 395 | 400 | PF02516 | 0.477 |
MOD_N-GLC_2 | 172 | 174 | PF02516 | 0.374 |
MOD_N-GLC_2 | 369 | 371 | PF02516 | 0.299 |
MOD_NEK2_1 | 115 | 120 | PF00069 | 0.278 |
MOD_NEK2_1 | 34 | 39 | PF00069 | 0.321 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.316 |
MOD_NEK2_1 | 428 | 433 | PF00069 | 0.712 |
MOD_PIKK_1 | 302 | 308 | PF00454 | 0.449 |
MOD_PK_1 | 253 | 259 | PF00069 | 0.216 |
MOD_PKA_2 | 152 | 158 | PF00069 | 0.426 |
MOD_PKA_2 | 218 | 224 | PF00069 | 0.375 |
MOD_PKA_2 | 275 | 281 | PF00069 | 0.737 |
MOD_PKA_2 | 59 | 65 | PF00069 | 0.161 |
MOD_PKB_1 | 181 | 189 | PF00069 | 0.305 |
MOD_Plk_1 | 28 | 34 | PF00069 | 0.414 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.335 |
MOD_Plk_4 | 144 | 150 | PF00069 | 0.335 |
MOD_Plk_4 | 212 | 218 | PF00069 | 0.426 |
MOD_Plk_4 | 321 | 327 | PF00069 | 0.370 |
MOD_Plk_4 | 376 | 382 | PF00069 | 0.441 |
MOD_Plk_4 | 41 | 47 | PF00069 | 0.391 |
MOD_Plk_4 | 59 | 65 | PF00069 | 0.391 |
MOD_ProDKin_1 | 317 | 323 | PF00069 | 0.513 |
MOD_ProDKin_1 | 351 | 357 | PF00069 | 0.402 |
MOD_ProDKin_1 | 413 | 419 | PF00069 | 0.619 |
MOD_SUMO_for_1 | 149 | 152 | PF00179 | 0.391 |
TRG_DiLeu_BaEn_1 | 312 | 317 | PF01217 | 0.522 |
TRG_ENDOCYTIC_2 | 12 | 15 | PF00928 | 0.342 |
TRG_ENDOCYTIC_2 | 145 | 148 | PF00928 | 0.324 |
TRG_ENDOCYTIC_2 | 353 | 356 | PF00928 | 0.421 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.416 |
TRG_ENDOCYTIC_2 | 69 | 72 | PF00928 | 0.143 |
TRG_ER_diArg_1 | 106 | 108 | PF00400 | 0.391 |
TRG_ER_diArg_1 | 180 | 183 | PF00400 | 0.305 |
TRG_NLS_MonoExtC_3 | 138 | 143 | PF00514 | 0.306 |
TRG_NLS_MonoExtN_4 | 136 | 143 | PF00514 | 0.305 |
TRG_Pf-PMV_PEXEL_1 | 110 | 114 | PF00026 | 0.406 |
TRG_Pf-PMV_PEXEL_1 | 201 | 206 | PF00026 | 0.194 |
TRG_Pf-PMV_PEXEL_1 | 314 | 319 | PF00026 | 0.447 |
TRG_Pf-PMV_PEXEL_1 | 87 | 91 | PF00026 | 0.305 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I267 | Leptomonas seymouri | 76% | 98% |
A0A0S4JAT8 | Bodo saltans | 47% | 100% |
A0A1X0NLQ1 | Trypanosomatidae | 53% | 99% |
A0A3Q8IJV9 | Leishmania donovani | 91% | 100% |
A0A422NSE7 | Trypanosoma rangeli | 52% | 99% |
A4HQ94 | Leishmania braziliensis | 81% | 100% |
A4IDZ2 | Leishmania infantum | 91% | 100% |
D0A417 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 97% |
P0CS06 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 27% | 83% |
P0CS07 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 27% | 83% |
P41814 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 24% | 97% |
Q2T9V5 | Bos taurus | 26% | 93% |
Q4Q0I3 | Leishmania major | 90% | 100% |
Q54UB1 | Dictyostelium discoideum | 29% | 89% |
Q5A6Q4 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 25% | 100% |
Q6BKK7 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 23% | 98% |
Q6CF35 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 24% | 95% |
Q6CLF6 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 24% | 97% |
Q6FNP9 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 23% | 98% |
Q75B32 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 23% | 100% |
Q8CE96 | Mus musculus | 26% | 93% |
Q9UJA5 | Homo sapiens | 27% | 93% |
V5B3L2 | Trypanosoma cruzi | 52% | 99% |